$ANCN Chemomab Therapeutics Ltd. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Chemomab Therapeutics Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Chemomab Therapeutics Ltd.. Insider overview, share value development, latest insider transactions and email notifications about new events in Chemomab Therapeutics Ltd. for free.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ANCN
Company Address: KIRYAT ATIDIM, BUILDING 7 TEL AVIV 6158002
Phone number: +972-77-331-0156
Former name: BioCancell Ltd., date of change: 2011-11-04
Former name: Anchiano Therapeutics Ltd., date of change: 2018-09-06
Chemomab Therapeutics Ltd. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | ANCN | Chemomab Therapeut ... | Fatal Sigal | Chief Financial Off ... | Option Exercise | A | 27.26 | 35,653 | 971,901 | 35,653 | |
| Apr 21 2021 | ANCN | Chemomab Therapeut ... | SQUINTO STEPHEN P | Director | Option Exercise | A | 27.26 | 23,768 | 647,916 | 23,768 | |
| Apr 21 2021 | ANCN | Chemomab Therapeut ... | Nicaise Claude | Director | Option Exercise | A | 27.26 | 11,884 | 323,958 | 11,884 | |
| Apr 21 2021 | ANCN | Chemomab Therapeut ... | Moses Alan Charles | Director | Option Exercise | A | 27.26 | 11,884 | 323,958 | 11,884 | |
| Apr 21 2021 | ANCN | Chemomab Therapeut ... | Maryles Joel Michael | Director | Option Exercise | A | 27.26 | 11,884 | 323,958 | 11,884 | |
| Apr 21 2021 | ANCN | Chemomab Therapeut ... | Darvish Nissim | Director | Option Exercise | A | 27.26 | 11,884 | 323,958 | 11,884 | |
| Apr 21 2021 | ANCN | Chemomab Therapeut ... | Cohen Neil Harris | Director | Option Exercise | A | 27.26 | 11,884 | 323,958 | 11,884 | |
| Mar 18 2021 | ANCN | Chemomab Therapeut ... | OrbiMed Israel GP Ltd. | 10% Owner | Option Exercise | A | 17.35 | 28,817 | 499,975 | 28,817 | |
| Mar 18 2021 | ANCN | Chemomab Therapeut ... | OrbiMed Israel GP Ltd. | 10% Owner | Grant | A | 17.35 | 288,170 | 4,999,750 | 2,578,174 | 2.3 M to 2.6 M (+12.58 %) |
| Mar 18 2021 | ANCN | Chemomab Therapeut ... | THIEL PETER | 10% Owner | Option Exercise | P | 17.35 | 23,054 | 400,008 | 23,054 | |
| Mar 18 2021 | ANCN | Chemomab Therapeut ... | THIEL PETER | 10% Owner | Buy | P | 0.00 | 230,536 | 0 | 1,108,509 | 878 K to 1.1 M (+26.26 %) |
| Mar 12 2021 | ANCN | Anchiano Therapeut ... | Polovets Stanislav | Director | Option Exercise | A | 0.17 | 55,000 | 9,350 | 55,000 | |
| Mar 11 2021 | ANCN | Anchiano Therapeut ... | Cohen Neil Harris | interim CEO | Option Exercise | A | 0.17 | 55,000 | 9,350 | 55,000 |